Scientific
MK5 Microarray Data

Affected Genes - Ontology Breakdown - Gene Enrichment - Proteome Analysis
These are the micro-array results of a differential gene expression microarray experiments and the subsequent analysis steps performed on them. The up/down- regulation ratio was obtained by measuring WT cells against MK5 activated cells. See material and methods for technical information as well as the data usage policy.
MK5 Proteome Analysis

Table 3: Type II network, divided ranks. This table presents the output of the simulation of a type-II network in which we relied on the high confidence interactions and micro-array results. The output of the micro-array was then ranked and these ranks used as input into the network simulation. After performing two such simulations (one for the MK5 off and one for the MK5 on microarray output), we divided the ranks and sorted the results accordingly. The output of this technique is a collection of proteins that cluster naturally together.
Navigation/Query Panel:
Click on the attribute name to hide/unhide it. The green arrows can be used to shift columns left/right. Exact word match is written as =..., regular expressions can be matched with ~.... To select all values larger or equal than use >.... This would be <... for values smaller or equal than. To select all values within a specific range use [...,...].
Rank Gene description Value Type Network Comparison Type Interaction Map Filtered red green network_comparison
Results: HTML CSV LaTeX
Showing element 2408 to 2457 of 3228 in total
Value Type: Ranked
Network Comparison Type: Divided
Interaction Map: High confidence
Filtered: 1

\def\wcA{0.16666666666667\textwidth}
\def\wcB{0.16666666666667\textwidth}
\def\wcC{0.16666666666667\textwidth}
\def\wcD{0.16666666666667\textwidth}
\def\wcE{0.16666666666667\textwidth}
\begin{longtable}{|c|c|c|c|c|}
\hline
\parbox{\wcA}{\vspace{3pt}\noindent
Rank\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
description\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
red\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
green\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
network\_comparison\vspace{3pt}}\\
\hline
\hline
\parbox{\wcA}{\vspace{3pt}\noindent
2408\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
dj570f3.6 (novel protein similar to lysophospholipase ii (lypla2)). [source:sptrembl;acc:q9uge0]\vspace{3pt}}&\multirow{5}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
194.407\vspace{3pt}}}&\multirow{5}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
193.706\vspace{3pt}}}&\multirow{5}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
1.00362\vspace{3pt}}}\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
2409\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
lactoylglutathione lyase (ec 4.4.1.5) (methylglyoxalase) (aldoketomutase) (glyoxalase i) (glx i) (ketone-aldehyde mutase) (s-d-lactoylglutathione methylglyoxal lyase). [source:swissprot;acc:q04760]\vspace{3pt}}&&&\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
2410\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
lysophospholipase i; lysophospholipase 1; lysophospholipid-specific lysophospholipase; acyl-protein thioesterase-1. [source:refseq;acc:nm\_006330]\vspace{3pt}}&&&\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
2411\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
mawd binding protein (unknown protein 32 from 2d-page of liver tissue). [source:swissprot;acc:p30039]\vspace{3pt}}&&&\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
2412\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
lysophospholipase ii; acyl-protein thioesterase. [source:refseq;acc:nm\_007260]\vspace{3pt}}&&&\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
2413\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
serpin b12. [source:swissprot;acc:q96p63]\vspace{3pt}}&\multirow{8}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
218.2\vspace{3pt}}}&\multirow{8}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
218.984\vspace{3pt}}}&\multirow{10}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
1.00359\vspace{3pt}}}\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
2414\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
megsin (tp55) (serpin b7). [source:swissprot;acc:o75635]\vspace{3pt}}&&&\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
2415\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
hurpin (hacat uv-repressible serpin) (protease inhibitor 13) (headpin) (serpin b13). [source:swissprot;acc:q9uiv8]\vspace{3pt}}&&&\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
2416\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
oxysterols receptor lxr-beta (liver x receptor beta) (nuclear orphan receptor lxr-beta) (ubiquitously-expressed nuclear receptor) (nuclear receptor ner). [source:swissprot;acc:p55055]\vspace{3pt}}&&&\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
2417\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
upf0183 protein. [source:swissprot;acc:q9bsu1]\vspace{3pt}}&&&\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
2418\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
antithrombin-iii precursor (atiii) (pro0309). [source:swissprot;acc:p01008]\vspace{3pt}}&&&\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
2419\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
translation initiation factor eif-2b alpha subunit (eif-2b gdp-gtp exchange factor). [source:swissprot;acc:q14232]\vspace{3pt}}&&&\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
2420\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
squamous cell carcinoma antigen 1 (scca-1) (protein t4-a). [source:swissprot;acc:p29508]\vspace{3pt}}&&&\\\cline{1-4}
\parbox{\wcA}{\vspace{3pt}\noindent
2421\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
apoptosis-inducing factor (aif)-homologous mitochondrion-associated inducer of death; p53-responsive gene 3. [source:refseq;acc:nm\_032797]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
210.205\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
209.454\vspace{3pt}}&\\\cline{1-4}
\parbox{\wcA}{\vspace{3pt}\noindent
2422\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
oxysterols receptor lxr-alpha (liver x receptor alpha) (nuclear orphan receptor lxr-alpha). [source:swissprot;acc:q13133]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
218.2\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
218.984\vspace{3pt}}&\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
2423\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
histone deacetylase 5 (hd5) (antigen ny-co-9). [source:swissprot;acc:q9uql6]\vspace{3pt}}&\multirow{3}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
220.682\vspace{3pt}}}&\parbox{\wcD}{\vspace{3pt}\noindent
221.471\vspace{3pt}}&\multirow{3}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
1.00358\vspace{3pt}}}\\\cline{1-2}\cline{4-4}
\parbox{\wcA}{\vspace{3pt}\noindent
2424\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
histone deacetylase 4 (hd4). [source:swissprot;acc:p56524]\vspace{3pt}}&&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
221.472\vspace{3pt}}}&\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
2425\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
histone deacetylase 9 (hd9) (hd7b) (hd7). [source:swissprot;acc:q9ukv0]\vspace{3pt}}&&&\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
2426\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
mesoderm induction early response 1. [source:refseq;acc:nm\_020948]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
212.374\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
211.618\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
1.00357\vspace{3pt}}}\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
2427\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
proteasome subunit alpha type 3 (ec 3.4.25.1) (proteasome component c8) (macropain subunit c8) (multicatalytic endopeptidase complex subunit c8). [source:swissprot;acc:p25788]\vspace{3pt}}&&&\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
2428\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
alcohol dehydrogenase class iii chi chain (ec 1.1.1.1) (glutathione- dependent formaldehyde dehydrogenase) (ec 1.2.1.1) (fdh). [source:swissprot;acc:p11766]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
192.871\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
193.555\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
1.00355\vspace{3pt}}}\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
2429\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
esterase d (ec 3.1.1.1). [source:swissprot;acc:p10768]\vspace{3pt}}&&&\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
2430\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
epsin 1; eh domain-binding mitotic phosphoprotein. [source:refseq;acc:nm\_013333]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
217.873\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
218.644\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.00354\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
2431\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
proteasome subunit alpha type 2 (ec 3.4.25.1) (proteasome component c3) (macropain subunit c3) (multicatalytic endopeptidase complex subunit c3). [source:swissprot;acc:p25787]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
213.048\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
212.3\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.00352\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
2432\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
26s proteasome non-atpase regulatory subunit 6 (26s proteasome regulatory subunit s10) (p42a) (proteasome regulatory particle subunit p44s10). [source:swissprot;acc:q15008]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
215.807\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
216.556\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.00347\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
2433\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
elongation factor 1-alpha 1 (ef-1-alpha-1) (elongation factor 1 a-1) (eef1a-1) (elongation factor tu) (ef-tu). [source:swissprot;acc:p04720]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
217.366\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
218.117\vspace{3pt}}&\multirow{4}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
1.00346\vspace{3pt}}}\\\cline{1-4}
\parbox{\wcA}{\vspace{3pt}\noindent
2434\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
methylenetetrahydrofolate reductase (ec 1.5.1.20). [source:swissprot;acc:p42898]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
213.021\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
212.286\vspace{3pt}}&\\\cline{1-4}
\parbox{\wcA}{\vspace{3pt}\noindent
2435\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
zinc-finger protein zpr1 (zinc finger protein 259). [source:swissprot;acc:o75312]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
217.366\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
218.117\vspace{3pt}}}&\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
2436\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
elongation factor 1-alpha 2 (ef-1-alpha-2) (elongation factor 1 a-2) (eef1a-2) (statin s1). [source:swissprot;acc:q05639]\vspace{3pt}}&&&\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
2437\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
guanylate kinase (ec 2.7.4.8) (gmp kinase). [source:swissprot;acc:q16774]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
219.361\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
220.116\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.00344\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
2438\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
proteasome subunit alpha type 4 (ec 3.4.25.1) (proteasome component c9) (macropain subunit c9) (multicatalytic endopeptidase complex subunit c9) (proteasome subunit l). [source:swissprot;acc:p25789]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
214.049\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
213.323\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.0034\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
2439\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
14-3-3 protein beta/alpha (protein kinase c inhibitor protein-1) (kcip-1) (protein 1054). [source:swissprot;acc:p31946]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
220.681\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
221.425\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.00337\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
2440\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
26s proteasome non-atpase regulatory subunit 3 (26s proteasome regulatory subunit s3) (proteasome subunit p58). [source:swissprot;acc:o43242]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
217.645\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
218.376\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.00336\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
2441\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
electron transfer flavoprotein alpha-subunit, mitochondrial precursor (alpha-etf). [source:swissprot;acc:p13804]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
180.137\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
180.732\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.0033\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
2442\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
transcription initiation factor tfiid 70 kda subunit (tafii-70) (tafii-80) (tafii80). [source:swissprot;acc:p49848]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
204.419\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
203.748\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.00329\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
2443\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
ubiquitin-like protein sumo-1 conjugating enzyme (ec 6.3.2.19) (sumo- 1-protein ligase) (ubiquitin carrier protein) (ubiquitin-conjugating enzyme ubce2a) (p18). [source:swissprot;acc:p50550]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
217.073\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
216.364\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.00328\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
2444\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
zinc finger protein 288 (dendritic-derived btb/poz zinc finger protein). [source:swissprot;acc:q9hc78]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
206.086\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
206.753\vspace{3pt}}&\multirow{4}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
1.00324\vspace{3pt}}}\\\cline{1-4}
\parbox{\wcA}{\vspace{3pt}\noindent
2445\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
kruppel-related zinc finger protein hckrox. [source:refseq;acc:nm\_015872]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
206.088\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
206.756\vspace{3pt}}&\\\cline{1-4}
\parbox{\wcA}{\vspace{3pt}\noindent
2446\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
epoxide hydrolase 1 (ec 3.3.2.3) (microsomal epoxide hydrolase) (epoxide hydratase). [source:swissprot;acc:p07099]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
182.272\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
181.683\vspace{3pt}}&\\\cline{1-4}
\parbox{\wcA}{\vspace{3pt}\noindent
2447\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
peroxisomal targeting signal 2 receptor (pts2 receptor) (peroxin-7). [source:swissprot;acc:o00628]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
206.084\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
206.752\vspace{3pt}}&\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
2448\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
glycine dehydrogenase [decarboxylating], mitochondrial precursor (ec 1.4.4.2) (glycine decarboxylase) (glycine cleavage system p- protein). [source:swissprot;acc:p23378]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
212.446\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
211.766\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.00321\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
2449\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
phosphatidate cytidylyltransferase 2 (ec 2.7.7.41) (cdp-diglyceride synthetase 2) (cdp-diglyceride pyrophosphorylase 2) (cdp- diacylglycerol synthase 2) (cds 2) (ctp:phosphatidate cytidylyltransferase 2) (cdp-dag synthase 2) (cdp-dg synthetase 2). [source:swissprot;acc:o95674]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
204.717\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
205.371\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.00319\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
2450\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
proteasome subunit beta type 6 precursor (ec 3.4.25.1) (proteasome delta chain) (macropain delta chain) (multicatalytic endopeptidase complex delta chain) (proteasome subunit y). [source:swissprot;acc:p28072]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
213.85\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
213.177\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
1.00316\vspace{3pt}}\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
2451\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
secretory carrier-associated membrane protein 2. [source:swissprot;acc:o15127]\vspace{3pt}}&\multirow{3}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
204.688\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
205.333\vspace{3pt}}}&\multirow{3}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
1.00315\vspace{3pt}}}\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
2452\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
secretory carrier-associated membrane protein 3. [source:swissprot;acc:o14828]\vspace{3pt}}&&&\\\cline{1-2}\cline{4-4}
\parbox{\wcA}{\vspace{3pt}\noindent
2453\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
secretory carrier-associated membrane protein 1. [source:swissprot;acc:o15126]\vspace{3pt}}&&\parbox{\wcD}{\vspace{3pt}\noindent
205.332\vspace{3pt}}&\\\hline
\parbox{\wcA}{\vspace{3pt}\noindent
2454\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
solute carrier family 13, member 4 (na+/sulfate cotransporter sut-1). [source:swissprot;acc:q9ukg4]\vspace{3pt}}&\multirow{3}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
204.683\vspace{3pt}}}&\multirow{3}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
205.326\vspace{3pt}}}&\multirow{4}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
1.00314\vspace{3pt}}}\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
2455\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
solute carrier family 13, member 3 (sodium-dependent high-affinity dicarboxylate transporter 2) (na(+)/dicarboxylate cotransporter 3) (nadc-3) (hnadc3). [source:swissprot;acc:q8wwt9]\vspace{3pt}}&&&\\\cline{1-2}
\parbox{\wcA}{\vspace{3pt}\noindent
2456\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
solute carrier family 13, member 1 (renal sodium/sulfate cotransporter) (na(+)/sulfate cotransporter) (hnasi-1). [source:swissprot;acc:q9bzw2]\vspace{3pt}}&&&\\\cline{1-4}
\parbox{\wcA}{\vspace{3pt}\noindent
2457\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
vesicle-fusing atpase (ec 3.6.4.6) (vesicular-fusion protein nsf) (n- ethylmaleimide sensitive fusion protein) (nem-sensitive fusion protein). [source:swissprot;acc:p46459]\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
213.588\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
212.92\vspace{3pt}}&\\\hline
nd{longtable}

Legend:
- Rank is the rank after comparing the two networks

 - Gene is the ensembl human gene identifier measured by 1 or more probes on the microarray

 - Value Type describes how the microarray measurement was processed. Ranked indicates that we sorted all measurements and use the rank as red and green value. Measured is the normal measurement. Squared and Rooted are the square and square root respecitcely. This might be valueable to compensate for non linear light distributions.

 - Network Comparison Type describes whether we divided the red and green types or whether we sutractcted them

 - Interaction Map specifies whether we used only the hig hconfidence protein-protein interactions or also included the low confidence interactions.

 - Filtered specifies whether we only included the high confidence microarry measurements or not.
- http://analysis.yellowcouch.org/